Wipro-GE Healthcare, a prominent player in medical technology and digital solutions, is set to invest Rs 8,000 crore over the next five years in India. This investment aims to strengthen its manufacturing output and research and development capabilities. The company’s focus is on expanding its ‘Make in India for the World’ initiative, emphasizing increased localization and exports of medical equipment.
Investment Details
- Wipro-GE Healthcare plans to invest Rs 8,000 crore in manufacturing output and research and development in India over the next five years.
- The investment aims to bolster the company’s focus on ‘Make in India for the World’, with an emphasis on localization and export-oriented production.
Product Focus
- Products slated for export include PET-CT for cancer diagnosis, CT, and MRI coils.
- The company aims to increase localization in manufacturing from 50% to 70-80%.
International Expansion
- Identified over 15 countries for exporting machines manufactured in India, including Southeast Asia, Eastern Europe, the European Union replacement market, and Latin America.
- Emphasizes the importance of local procurement in India over importing components from China due to potential cost advantages.